Periscope Capital’s Celularity Inc CELUW Stock Holding History

Periscope Capital’s Portfolio CELUW Stock Details CELUW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-240,028	Closed	-$383K	–	358
2020 Q3	$383K	Buy	240,028 +110,028	+85%	+$166K	0.03%	223
2020 Q2	$142K	Sell	130,000 -46,000	-26%	-$30.3K	0.01%	196
2020 Q1	$89K	Hold	176,000	–	–	0.01%	184
2019 Q4	$141K	Hold	176,000	–	–	0.02%	169
2019 Q3	$104K	Buy	+176,000	New	+$101K	0.01%	180

Other funds holding CELUW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

NFAM

North Fourth Asset Management Englewood Cliffs, New Jersey $164M AUM 43.6% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Periscope Capital's CELUW Position: Q4 2020 in Review

Periscope Capital sold out of Celularity Inc (CELUW) in Q4 2020, closing a stake of 240,028 shares — an estimated $383K sold.

Periscope Capital first reported a position in CELUW in Q3 2019 and held it in 5 quarters. The position peaked at $383K in Q3 2020. 31 funds tracked by Wall St. Rank hold CELUW as of Q4 2020.

Periscope Capital reported no remaining Celularity Inc position as of Q4 2020 after selling out during the quarter.
Periscope Capital sold 240,028 Celularity Inc shares in Q4 2020, an estimated $383K.
Periscope Capital first reported a position in Celularity Inc in Q3 2019 and held it in 5 quarters.
Periscope Capital's Celularity Inc position peaked at $383K in Q3 2020.
31 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2020.

Based on Periscope Capital's 13F filing for Q4 2020, filed 10 Feb 2021.